Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldesleukin for prevention of early miscarriage in immune-mediated pregnancy loss
2018-003635-30Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2018
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of aldesleukin in Early pregnancy failure (EPF) and Immune disorder, sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2018; status: completed.
02
Drugs
aldesleukin
03
Conditions
Early pregnancy failure (EPF)Immune disorder
Beyond the preview
Go deeper on 2018-003635-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003635-30.